Risk-sharing in the Pharmaceutical Industry The Case of Out-licensing /
The costs of developing a new drug have reached record levels in the pharmaceutical industry. As any failure of a new drug candidate can lead to significant losses, many pharmaceutical companies are looking for new approaches to reduce their exposure to R&D risks. In this context, the book deals...
Uloženo v:
| Hlavní autor: | |
|---|---|
| Korporativní autor: | |
| Médium: | Elektronický zdroj E-kniha |
| Jazyk: | English |
| Vydáno: |
Heidelberg :
Physica-Verlag HD : Imprint: Physica,
2006.
|
| Vydání: | 1st ed. 2006. |
| Edice: | Contributions to Management Science,
|
| Témata: | |
| On-line přístup: | https://doi.org/10.1007/3-7908-1668-X |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|